197 related articles for article (PubMed ID: 17218104)
1. Benzoic acid and pyridine derivatives as inhibitors of Trypanosoma cruzi trans-sialidase.
Neres J; Bonnet P; Edwards PN; Kotian PL; Buschiazzo A; Alzari PM; Bryce RA; Douglas KT
Bioorg Med Chem; 2007 Mar; 15(5):2106-19. PubMed ID: 17218104
[TBL] [Abstract][Full Text] [Related]
2. Development of new and selective Trypanosoma cruzi trans-sialidase inhibitors from sulfonamide chalcones and their derivatives.
Kim JH; Ryu HW; Shim JH; Park KH; Withers SG
Chembiochem; 2009 Oct; 10(15):2475-9. PubMed ID: 19780074
[TBL] [Abstract][Full Text] [Related]
3. Structure-Based Virtual Screening of New Benzoic Acid Derivatives as Trypanosoma cruzi Trans-sialidase Inhibitors.
Vázquez-Jiménez LK; Paz-González AD; Juárez-Saldivar A; Uhrig ML; Agusti R; Reyes-Arellano A; Nogueda-Torres B; Rivera G
Med Chem; 2021; 17(7):724-731. PubMed ID: 32370720
[TBL] [Abstract][Full Text] [Related]
4. Donor substrate binding to trans-sialidase of Trypanosoma cruzi as studied by STD NMR.
Blume A; Neubacher B; Thiem J; Peters T
Carbohydr Res; 2007 Sep; 342(12-13):1904-9. PubMed ID: 17597593
[TBL] [Abstract][Full Text] [Related]
5. Potent inhibitor scaffold against Trypanosoma cruzi trans-sialidase.
Arioka S; Sakagami M; Uematsu R; Yamaguchi H; Togame H; Takemoto H; Hinou H; Nishimura S
Bioorg Med Chem; 2010 Feb; 18(4):1633-40. PubMed ID: 20097567
[TBL] [Abstract][Full Text] [Related]
6. Rational drug design in parasitology: trans-sialidase as a case study for Chagas disease.
Neres J; Bryce RA; Douglas KT
Drug Discov Today; 2008 Feb; 13(3-4):110-7. PubMed ID: 18275908
[TBL] [Abstract][Full Text] [Related]
7. A new class of mechanism-based inhibitors for Trypanosoma cruzi trans-sialidase and their influence on parasite virulence.
Carvalho ST; Sola-Penna M; Oliveira IA; Pita S; Gonçalves AS; Neves BC; Sousa FR; Freire-de-Lima L; Kurogochi M; Hinou H; Nishimura S; Mendonça-Previato L; Previato JO; Todeschini AR
Glycobiology; 2010 Aug; 20(8):1034-45. PubMed ID: 20466651
[TBL] [Abstract][Full Text] [Related]
8. A new generation of specific Trypanosoma cruzi trans-sialidase inhibitors.
Buchini S; Buschiazzo A; Withers SG
Angew Chem Int Ed Engl; 2008; 47(14):2700-3. PubMed ID: 18300214
[No Abstract] [Full Text] [Related]
9. Continuous fluorimetric assay for high-throughput screening of inhibitors of trans-sialidase from Trypanosoma cruzi.
Neres J; Buschiazzo A; Alzari PM; Walsh L; Douglas KT
Anal Biochem; 2006 Oct; 357(2):302-4. PubMed ID: 16930524
[No Abstract] [Full Text] [Related]
10. Discovery of novel inhibitors of Trypanosoma cruzi trans-sialidase from in silico screening.
Neres J; Brewer ML; Ratier L; Botti H; Buschiazzo A; Edwards PN; Mortenson PN; Charlton MH; Alzari PM; Frasch AC; Bryce RA; Douglas KT
Bioorg Med Chem Lett; 2009 Feb; 19(3):589-96. PubMed ID: 19144516
[TBL] [Abstract][Full Text] [Related]
11. Lactose derivatives are inhibitors of Trypanosoma cruzi trans-sialidase activity toward conventional substrates in vitro and in vivo.
Agustí R; París G; Ratier L; Frasch AC; de Lederkremer RM
Glycobiology; 2004 Jul; 14(7):659-70. PubMed ID: 15070857
[TBL] [Abstract][Full Text] [Related]
12. Sialic acid C-glycosides with aromatic residues: investigating enzyme binding and inhibition of Trypanosoma cruzi trans-sialidase.
Meinke S; Schroven A; Thiem J
Org Biomol Chem; 2011 Jun; 9(12):4487-97. PubMed ID: 21528140
[TBL] [Abstract][Full Text] [Related]
13. Trans-sialidase and mucins of Trypanosoma cruzi: an important interplay for the parasite.
Giorgi ME; de Lederkremer RM
Carbohydr Res; 2011 Sep; 346(12):1389-93. PubMed ID: 21645882
[TBL] [Abstract][Full Text] [Related]
14. Trypanosoma cruzi trans-sialidase as a drug target against Chagas disease (American trypanosomiasis).
Miller BR; Roitberg AE
Future Med Chem; 2013 Oct; 5(15):1889-900. PubMed ID: 24144418
[TBL] [Abstract][Full Text] [Related]
15. Trypanosoma cruzi trans-sialidase operates through a covalent sialyl-enzyme intermediate: tyrosine is the catalytic nucleophile.
Watts AG; Damager I; Amaya ML; Buschiazzo A; Alzari P; Frasch AC; Withers SG
J Am Chem Soc; 2003 Jun; 125(25):7532-3. PubMed ID: 12812490
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and inhibitory activity of benzoic acid and pyridine derivatives on influenza neuraminidase.
Chand P; Kotian PL; Morris PE; Bantia S; Walsh DA; Babu YS
Bioorg Med Chem; 2005 Apr; 13(7):2665-78. PubMed ID: 15755666
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and the effect of 1,2,3-triazole sialylmimetic neoglycoconjugates on Trypanosoma cruzi and its cell surface trans-sialidase.
Campo VL; Sesti-Costa R; Carneiro ZA; Silva JS; Schenkman S; Carvalho I
Bioorg Med Chem; 2012 Jan; 20(1):145-56. PubMed ID: 22154559
[TBL] [Abstract][Full Text] [Related]
18. Recent developments in trans-sialidase inhibitors of Trypanosoma cruzi.
Kashif M; Moreno-Herrera A; Lara-Ramirez EE; Ramírez-Moreno E; Bocanegra-García V; Ashfaq M; Rivera G
J Drug Target; 2017 Jul; 25(6):485-498. PubMed ID: 28140698
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design.
Chand P; Babu YS; Bantia S; Chu N; Cole LB; Kotian PL; Laver WG; Montgomery JA; Pathak VP; Petty SL; Shrout DP; Walsh DA; Walsh GM
J Med Chem; 1997 Dec; 40(25):4030-52. PubMed ID: 9406595
[TBL] [Abstract][Full Text] [Related]
20. Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent.
Atigadda VR; Brouillette WJ; Duarte F; Ali SM; Babu YS; Bantia S; Chand P; Chu N; Montgomery JA; Walsh DA; Sudbeck EA; Finley J; Luo M; Air GM; Laver GW
J Med Chem; 1999 Jul; 42(13):2332-43. PubMed ID: 10395473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
